0001437749-23-031986.txt : 20231114
0001437749-23-031986.hdr.sgml : 20231114
20231114161924
ACCESSION NUMBER: 0001437749-23-031986
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231114
DATE AS OF CHANGE: 20231114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Purav
CENTRAL INDEX KEY: 0001818246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38634
FILM NUMBER: 231406645
MAIL ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REVIVA PHARMACEUTICALS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001742927
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD.
STREET 2: SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 4085018881
MAIL ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD.
STREET 2: SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: Tenzing Acquisition Corp.
DATE OF NAME CHANGE: 20180606
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-11-13
0001742927
REVIVA PHARMACEUTICALS HOLDINGS, INC.
RVPH
0001818246
Patel Purav
C/O REVIVA PHARMACEUTICALS HOLDINGS, INC
19925 STEVENS CREEK BLVD, SUITE 100
CUPERTINO
CA
95014
1
0
Stock Option (right to buy)
6.04
2023-11-13
4
A
0
8200
0
A
2033-11-12
Common Stock, par value $0.0001 per share
8200
8200
D
The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan.
/s/ Narayan Prabhu, attorney-in-fact for Purav Patel
2023-11-14